Dipexium Pharmaceut (DPRX) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts DPRX Hot Sheet
Join SI Premium – FREE
Dipexium Pharmaceut (NASDAQ: DPRX) reported Q2 EPS of ($0.52), $0.02 better than the analyst estimate of ($0.54).
For earnings history and earnings-related data on Dipexium Pharmaceut (DPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- L3Harris CEO steps down amid conduct review, shares drop
- Nuvve Holdin (NVVE) Misses Q2 EPS by 1445c
- Laser Photonics Corporation (LASE) Reports Q2 Loss of $0.08
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
